Aurobindo Pharma falls 6% after USFDA classifies inspection as OAI

Aurobindo Pharma has already submitted its initial response to USFDA

from Latest News http://bit.ly/2Jr6W8o

Facebook Google Twitter More

• Pinterest
• Linkedin
• Tumblr

Posted by : Camera Guru 12:33 pm Tags : Latest News

Subscribe by Email

Follow Updates Articles from This Blog via Email